Avalo Therapeutics, Inc. (AVTX) quarterly income statement — complete revenue, gross profit & net income history
Avalo Therapeutics, Inc. (AVTX) annual income statement — 14-year revenue, gross profit & net income history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 59K | 0 | 0 | 0 | 192K | 249K | 0 | 0 | 571K | 236K | 643K | 475K | 896K | 14.95M | 1.03M | 1.17M | 219K |
| Revenue Growth % | - | - | - | -69.27% | -100% | - | - | -66.37% | 5.51% | -100% | -100% | -36.27% | -98.42% | -37.75% | -59.51% | 309.13% | 1007.33% | -69.21% | 147.99% | -85.37% |
| Cost of Goods Sold | 0 | 0 | 17K | 0 | 9.99M | 10.66M | 5.91M | 87K | -714K | 343K | -80K | -221K | 240K | 708K | 4.98M | 620K | 528K | 1.57M | 720K | 8.76M |
| COGS % of Revenue | - | - | - | - | - | - | - | 45.31% | -286.75% | - | - | -38.7% | 101.69% | 110.11% | 1049.05% | 69.2% | 3.53% | 151.69% | 61.38% | 4000% |
| Gross Profit | 0 | 0 | -17K | 59K | -9.99M | -10.66M | -5.91M | 105K | 963K | -343K | 80K | 792K | -4K | -65K | -4.51M | 276K | 14.42M | -534K | 453K | -8.54M |
| Gross Margin % | - | - | - | 100% | - | - | - | 54.69% | 386.75% | - | - | 138.7% | -1.69% | -10.11% | -949.05% | 30.8% | 96.47% | -51.69% | 38.62% | -3900% |
| Gross Profit Growth % | 100% | 100% | 99.71% | -43.81% | -1137.38% | -3007.87% | -7490% | -86.74% | 24175% | -427.69% | 101.77% | 186.96% | -100.03% | 87.83% | -1095.14% | 103.23% | 3162.67% | 91.91% | 14.39% | 6.29% |
| Operating Expenses | 23.4M | 31.52M | 20.88M | 19.8M | 9.21M | 8.66M | 8.76M | 13.42M | 13.82M | 9.23M | 32.85M | 4.54M | 3.75M | 7.08M | 4.28M | 9.13M | 10.33M | 11.29M | 21.31M | 9.42M |
| OpEx % of Revenue | - | - | - | 33561.02% | - | - | - | 6987.5% | 5551.81% | - | - | 795.62% | 1587.29% | 1101.87% | 901.89% | 1019.08% | 69.07% | 1093.32% | 1816.37% | 4302.28% |
| Selling, General & Admin | 8.35M | 8.1M | 6.84M | 6.53M | 5.58M | 5.24M | 5.55M | 5.23M | 4.29M | 4.53M | 3.19M | 2.68M | 2.49M | 2.43M | 2.71M | 2.96M | 3.28M | 2.78M | 11.68M | 5.98M |
| SG&A % of Revenue | - | - | - | 11074.58% | - | - | - | 2725.52% | 1721.29% | - | - | 468.65% | 1055.08% | 377.45% | 570.11% | 330.25% | 21.97% | 269.51% | 996.08% | 2731.05% |
| Research & Development | 15.05M | 23.42M | 14.05M | 13.27M | 13.62M | 14.07M | 9.12M | 8.18M | 9.54M | 4.7M | 29.65M | 1.87M | 1.25M | 4.66M | 6.01M | 6.17M | 7.04M | 8.51M | 9.58M | 11.51M |
| R&D % of Revenue | - | - | - | 22486.44% | - | - | - | 4261.98% | 3830.52% | - | - | 326.97% | 529.24% | 724.42% | 1264.84% | 688.84% | 47.11% | 823.81% | 817.05% | 5255.71% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | -1000K | -1000K | -1000K | 0 | 0 | 0 | 0 | 0 | 7K | 0 | -1000K | 0 | 0 | 0 | 38K | -1000K |
| Operating Income | -23.4M | -31.52M | -20.9M | -19.74M | -19.2M | -19.32M | -14.67M | -13.31M | -12.86M | -9.57M | -32.77M | -3.75M | -3.75M | -7.15M | -8.79M | -8.86M | 4.09M | -11.83M | -20.85M | -17.96M |
| Operating Margin % | - | - | - | -33461.02% | - | - | - | -6932.81% | -5165.06% | - | - | -656.92% | -1588.98% | -1111.98% | -1850.95% | -988.28% | 27.39% | -1145.01% | -1777.75% | -8202.28% |
| Operating Income Growth % | -21.87% | -63.17% | -42.48% | -48.31% | -49.27% | -101.73% | 55.23% | -254.87% | -242.96% | -33.92% | -272.69% | 57.64% | -191.58% | 39.55% | 57.84% | 50.7% | 124.87% | 55.49% | 31.81% | 75.34% |
| EBITDA | -23.4M | -31.5M | -20.88M | -19.73M | -19.14M | -19.18M | -14.53M | -13.24M | -12.83M | -9.54M | -32.73M | -3.71M | -3.71M | -7.11M | -8.76M | -8.82M | 4.13M | -11.8M | -20.79M | -17.67M |
| EBITDA Margin % | - | - | - | -33433.9% | - | - | - | -6897.4% | -5151.41% | - | - | -649.39% | -1571.61% | -1105.6% | -1844% | -984.38% | 27.62% | -1142.11% | -1772.04% | -8067.58% |
| EBITDA Growth % | -22.25% | -64.22% | -43.69% | -48.95% | -49.21% | -101.03% | 55.6% | -257.15% | -245.83% | -34.22% | -273.71% | 57.96% | -189.83% | 39.74% | 57.86% | 50.08% | 125.79% | 54.83% | 31.01% | 75.56% |
| D&A (Non-Cash Add-back) | 0 | 17K | 17K | 16K | 59K | 134K | 135K | 68K | 34K | 33K | 34K | 43K | 41K | 41K | 33K | 35K | 34K | 30K | 67K | 295K |
| EBIT | 0 | -36.34M | -19.62M | -13.59M | -30.61M | -20.75M | -13.14M | -35.23M | 23.02M | 98.47M | -121.28M | -8.26M | -3.75M | -7.15M | -8.79M | -8.86M | 4.09M | -11.83M | -20.87M | -17.96M |
| Net Interest Income | 0 | 2.76M | 803K | 992K | 1.12M | 1.1M | 1.15M | 1.22M | 964K | 1.04M | 100K | 81K | -1.55M | -996K | -949K | -949K | -898K | -1.15M | -1.17M | -1.18M |
| Interest Income | 0 | 2.76M | 803K | 992K | 1.12M | 1.1M | 1.15M | 1.22M | 964K | 1.04M | 100K | 81K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.55M | 996K | 949K | 949K | 898K | 1.15M | 1.17M | 1.18M |
| Other Income/Expense | 4.46M | -4.82M | 1.28M | 6.15M | -11.42M | -1.43M | 1.53M | -21.91M | 35.88M | 108.05M | -88.52M | -4.43M | -1.47M | -1.04M | -1.16M | -949K | -898K | -1.15M | -1.19M | -1.15M |
| Pretax Income | -18.94M | -36.34M | -19.62M | -13.59M | -30.61M | -20.75M | -13.14M | -35.23M | 23.02M | 98.47M | -121.28M | -8.18M | -5.22M | -8.19M | -9.95M | -9.8M | 3.2M | -12.98M | -22.04M | -19.12M |
| Pretax Margin % | - | - | - | -23033.9% | - | - | - | -18346.35% | 9246.18% | - | - | -1432.05% | -2211.86% | -1273.09% | -2094.11% | -1094.2% | 21.39% | -1256.73% | -1879.11% | -8728.31% |
| Income Tax | 7K | 18K | 12K | 130K | 11K | 16K | 8K | 114K | -14K | 7K | 7K | -9K | 8K | 7K | 8K | 8K | 5K | 5K | 9K | 16K |
| Effective Tax Rate % | -0.04% | -0.05% | -0.06% | -0.96% | -0.04% | -0.08% | -0.06% | -0.32% | -0.06% | 0.01% | -0.01% | 0.11% | -0.15% | -0.09% | -0.08% | -0.08% | 0.16% | -0.04% | -0.04% | -0.08% |
| Net Income | -18.95M | -36.36M | -19.63M | -13.72M | -30.63M | -20.77M | -13.15M | -35.34M | 23.04M | 98.46M | -121.29M | -8.17M | -5.23M | -8.19M | -9.96M | -9.81M | 3.19M | -12.99M | -22.05M | -19.2M |
| Net Margin % | - | - | - | -23254.24% | - | - | - | -18405.73% | 9251.81% | - | - | -1430.47% | -2215.25% | -1274.18% | -2095.79% | -1095.09% | 21.35% | -1257.21% | -1879.88% | -8765.3% |
| Net Income Growth % | 38.14% | -75.09% | -49.29% | 61.18% | -232.94% | -121.09% | 89.16% | -332.65% | 540.65% | 1301.79% | -1118.38% | 16.75% | -263.78% | 36.91% | 54.85% | 48.89% | 118.35% | 24.07% | 28.13% | -22.71% |
| Net Income (Continuing) | -18.95M | -36.36M | -19.63M | -13.72M | -30.63M | -20.77M | -13.15M | -35.34M | 23.04M | 98.46M | -121.29M | -8.17M | -5.23M | -8.19M | -9.96M | -9.81M | 3.19M | -12.99M | -22.05M | -19.13M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -65K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.34 | -0.83 | -0.98 | -0.74 | -2.19 | -1.92 | -1.25 | 10.47 | 2.14 | 12.87 | -141.14 | -10.19 | -26.83 | -140.73 | -203.81 | -249.99 | 81.38 | -331.55 | -563.03 | -484.39 |
| EPS Growth % | 84.47% | 56.77% | 21.6% | -107.07% | -202.34% | -114.92% | 99.11% | 202.75% | 107.98% | 109.15% | 30.75% | 95.92% | -132.97% | 57.55% | 63.8% | 48.39% | 116.32% | 26.9% | 39.55% | 12.61% |
| EPS (Basic) | -0.34 | -0.83 | -0.98 | -0.74 | -2.19 | -1.92 | -1.25 | 13.89 | 2.83 | 95.21 | -141.14 | -10.19 | -26.83 | -140.73 | -203.81 | -249.99 | 81.38 | -331.55 | -563.03 | -484.39 |
| Diluted Shares Outstanding | 55.06M | 43.6M | 20.11M | 18.51M | 14M | 10.83M | 10.51M | 10.47M | 10.78M | 7.65M | 859.38K | 801.75K | 194.85K | 58.22K | 48.84K | 39.25K | 39.22K | 39.17K | 39.16K | 39.63K |
| Basic Shares Outstanding | 55.06M | 43.6M | 20.11M | 18.51M | 14M | 10.83M | 10.51M | 10.47M | 5.55M | 1.03M | 859.38K | 801.75K | 194.85K | 58.22K | 48.84K | 39.25K | 39.22K | 39.17K | 39.16K | 39.63K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |